[#item_full_content] The December 18 EO to reclassify cannabis as Schedule III is a game-changer, transforming the industry from speculative to professional. Will this shift unleash new opportunities for medical and pharmaceutical applications? Follow @INN_Lifescience for updates as the cannabis market evolves! 🌿💼
Read More
